Chromosome 18 Clinical Research Center
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Sep 23, 2005
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Chromosome 18 Clinical Research Center is conducting a study aimed at improving the lives of individuals with chromosome 18 abnormalities, which can lead to various health challenges, including growth hormone deficiency and issues with brain development. The researchers at the University of Texas Health Science Center in San Antonio want to provide families with important medical and educational resources while also advancing research to find effective treatments. The trial is currently looking for participants, including individuals diagnosed with a chromosome 18 abnormality and their parents or guardians, who are at least one year old and in good health.
Eligible participants can expect to undergo clinical examinations to help the researchers better understand the effects of these chromosome abnormalities. It is important to note that pregnant women, certain newborns, and prisoners will not be able to participate in this study. Overall, this trial represents a valuable opportunity for families affected by chromosome 18 issues to contribute to research that may lead to better support and treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have a confirmed diagnosis of Chromosome 18 or be the parent/guardian of a child with Chromosome 18
- • Subject must be at least one year of age to participate in the clinical examination aspect of the study (due to issues of venous access and blood volume required to complete studies)
- • General health status: good
- Exclusion Criteria:
- • Pregnant women
- • Dead fetuses
- • Prisoners
- • Non-viable neonates or neonates of uncertain viability
About The University Of Texas Health Science Center At San Antonio
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical institution dedicated to advancing health through education, research, and patient care. As a prominent sponsor of clinical trials, UT Health San Antonio focuses on innovative medical research aimed at improving health outcomes across diverse populations. With a commitment to excellence, the institution fosters collaboration among its multidisciplinary teams to explore cutting-edge therapies and interventions. Through rigorous scientific inquiry and ethical practices, UT Health San Antonio strives to make meaningful contributions to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
San Antonio, Texas, United States
Patients applied
Trial Officials
Jannine D. Cody, Ph.D.
Principal Investigator
The University of Texas Health Science Center at San Antonio
Jonathan Gelfond, M.D., Ph.D.
Principal Investigator
The University of Texas Health Science Center at San Antonio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials